title: Imaging in neuroblastoma: An update.
abstract: Neuroblastoma is the third common tumor in children. Imaging plays an important role in the diagnosis, staging, treatment planning, response evaluation and in follow-up of a case of Neuroblastoma. The International Neuroblastoma Risk Group task force has recently introduced an imaging-based staging system and laid down guidelines for uniform reporting of imaging studies. This review is an update on imaging in neuroblastoma, with emphasis on these guidelines.
authors.affiliation: Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India.
authors.forename: Seema A
authors.initials: SA
authors.lastname: Kembhavi
authors.affiliation: Department of Bio-imaging, Tata Memorial Centre, Mumbai, Maharashtra, India.
authors.forename: Sneha
authors.initials: S
authors.lastname: Shah
authors.affiliation: Department of Bio-imaging, Tata Memorial Centre, Mumbai, Maharashtra, India.
authors.forename: Venkatesh
authors.initials: V
authors.lastname: Rangarajan
authors.affiliation: Department of Surgery, Tata Memorial Centre, Mumbai, Maharashtra, India.
authors.forename: Sajid
authors.initials: S
authors.lastname: Qureshi
authors.affiliation: Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India.
authors.forename: Palak
authors.initials: P
authors.lastname: Popat
authors.affiliation: Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
authors.forename: Purna
authors.initials: P
authors.lastname: Kurkure
keywords: Image-defined risk factor; international neuroblastoma risk group staging system; metaiodobenzylguanidine; neuroblastoma